Jessica Lin
Principal, Healthcare and Life Sciences Strategy
Jessica is a Principal in KPMG’s Healthcare and Life Sciences Deal Advisory and Strategy Practice. Jessica helps her life sciences clients develop the organic and inorganic strategies to grow their businesses, conducts commercial due diligence on potential acquisition targets, and provides PMO and operational support to stand up new business units.
Jessica earned an MS in mechanical engineering (focused on bioengineering) and an MBA, both from MIT, and she leverages both her scientific and business background when serving her clients. Prior to KPMG, Jessica was a Vice President at EY-Parthenon and a case team leader in Decision Resources’ life sciences strategy consulting arm, where she developed and executed growth strategy initiatives for her biopharma, diagnostics, and medical devices clients. Early in her career, Jessica conducted bench research in cartilage tissue engineering, synthetic biology, and drug encapsulation at the University of California research labs and at Amylin Pharmaceuticals.